Health Care/Hospital

Initiation of a Phase 2 Multicenter Study of 18F-APN-1607, a Novel Diagnostic PET Imaging Tracer for the Characterization of Tau Burden in Alzheimer's Disease

TAIPEI, Nov. 21, 2019 /PRNewswire/ -- APRINOIA Therapeutics, Inc. announced today that it has initiated a Phase 2 multicenter, multinational study of18F -APN-1607 in the US for its lead tau positron emission tomography (PET) tracer in Alzheimer's Disease (AD). The study (NCT number: NCT04141150) w...

2019-11-21 23:00 301

Seed Health Announces Research Partnership with Atmo Biosciences to Evaluate Impact of Probiotics With First Ingestible Gas Sensor Technology

First tech-enabled clinical trial will use new biomarkers to measure effect of Seed's Daily Synbiotic on gut microbiome after antibiotic use LOS ANGELES, Nov. 21, 2019 /PRNewswire/ -- Seed Health, a microbial sciences company, today announced a research partnership with digital health company, At...

2019-11-21 21:00 327

AnaPath Services Acquires Envigo CRS S.A.U. in Barcelona to provide full services in non-clinical safety assessment for chemical and pharmaceutical industries

GENEVA, Nov. 21, 2019 /PRNewswire/ -- AnaPath Services GmbH, the Swiss CRO specialized in histopathology, has acquired legacy Envigo CRS S.A.U. a CRO for non-clinical safety assessment onNovember 5th, 2019. With this step Envigo CRS was renamed to AnaPath Research S.A.U. Furthermore JorgeZapate...

2019-11-21 17:32 269

The 2nd East Tech West Forum Kicked off in Guangzhou's Nansha

GUANGZHOU, China, Nov. 21, 2019 /PRNewswire/ -- Over 300 most influential global industry leaders convened in the Nansha district ofGuangzhou, China from November 18 to 20 for the second East Tech West, a global forum organized by CNBC. Its focus is on the innovation and development of such indus...

2019-11-21 14:33 288

Ascentage Pharma Breaks Ground on its Global Headquarters, R&D Center and Manufacturing Facility in the Suzhou Industrial Park

SUZHOU, China and ROCKVILLE, Md., Nov. 20, 2019 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies, announced that the groundbreaking ceremony for the Company's global headquarters, R&D center, and manufacturi...

2019-11-21 11:30 415

Two Prominent Researchers of WPI-MANA and University of Washington Discuss Development of Smart Polymers and Biomaterials

TSUKUBA, Japan, Nov. 20, 2019 /PRNewswire/ -- The International Center for Materials Nanoarchitectonics (WPI-MANA), a unit of the National Institute for Materials Science (NIMS), had a visit from Prof.Allan S. Hoffman from the University of Washington, a pioneer in smart polymers and biomaterials...

2019-11-20 14:00 212

Conversational AI leader announces OrbitaASSIST, a digitally reimagined voice-powered, AI-driven virtual health assistant proven to improve patient communication at the bedside

BOSTON and SYDNEY, Nov. 19, 2019 /PRNewswire/ -- Orbita, the provider of healthcare's most powerful conversational AI platform, announced today that it is now offering OrbitaASSIST, an award-winning, voice-enabled, AI-driven bedside virtual health assistant. This market-proven solution offers an...

2019-11-19 21:33 457

Burning Rock Dx Launches Magnis BR to Innovate Total Process Automation for NGS Testing

ZHENGZHOU, Nov. 19, 2019 /PRNewswire/ -- Today, Agilent Technologies and Guangzhou Burning Rock Medical Laboratory Co., Ltd. ("Burning Rock Dx") jointly held a product launch event on Magnis BR, an automated next generation sequencing (NGS) library preparation system, to announce that Magnis BR i...

2019-11-19 21:00 379

Edan to Highlight Its New Developments at MEDICA 2019

DUSSELDORF, Germany, Nov. 19, 2019 /PRNewswire/ -- Edan, a healthcare solutions provider, revealed their latest product series in its all five product lines, including Obstetrics and Gynecology, Patient Monitoring, In-Vitro Diagnostics, Diagnostic ECG, and Ultrasound, bringing a huge surprise to ...

2019-11-19 18:18 198

ABL Bio Inc.- GenScript Biotech Corp Bispecific Antibody Strategic Partnership Agreement Ceremony

NANJING, China and SEOUL, South Korea, Nov. 18, 2019 /PRNewswire/ -- GenScript Biologics, a world leading bio-pharmaceutical CDMO company, announced today that it entered into an agreement with ABL Bio Inc., a South Korean biotech company dedicated to therapeutics for immuno-oncology and neurodeg...

2019-11-18 22:00 305

Plant Nanny 2, the Self-care Water Consumption Reminding app Has Been Nominated for "Google Play Best of 2019" Launches Brand New Version 2.0

TAIPEI, Nov. 18, 2019 /PRNewswire/ -- About 70% of human body is composed of water. However, according to the Quench Survey, nearly 80% of working Americans say they don't drink enough water. Keeping hydrated is crucial for a person's health and well-being, but there is a substantial amount of pe...

2019-11-18 14:30 208

Yili launches "Yili Future Intelligence and Health Valley" to promote health industry dev.

BEIJING, Nov. 17, 2019 /PRNewswire/ -- China's dairy giant Inner Mongolia Yili Industrial Group on Sunday launched the project of "Yili Future Intelligence and Health Valley" in Hohhot, capital of northChina's Inner Mongolia Autonomous Region, striving for boosting the health industry in the regi...

2019-11-18 12:05 306

3SBio Selects Verseau's PSGL-1-targeted Antibody VTX-0811 as First Partnered Macrophage Checkpoint Modulator in Immuno-Oncology Collaboration

SHENYANG, China and BEDFORD Mass., Nov. 17, 2019 /PRNewswire/ -- 3SBio Inc. ("3SBio") (HKEX:1530) and Verseau Therapeutics, Inc.  ("Verseau") today announced the selection of VTX-0811, a monoclonal antibody targeting PSGL-1, as the first lice...

2019-11-18 08:30 2267

China Pharma Holdings, Inc. Reports Third Quarter 2019 Financial Results

HAIKOU CITY, China, Nov. 15, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced financial results for the qu...

2019-11-15 21:00 5295

Viva Biotech Partnership Summit Successfully Launched in Shanghai

SHANGHAI, Nov. 15, 2019 /PRNewswire/ -- 2019 Viva Biotech Partnership Summit (the "Summit") was successfully launched on8 November 2019 in Pudong, Shanghai, themed "Innovation Partnership Growth". Founders from over 30 global innovative and biopharmaceutical companies incubated/ invested by Viva ...

2019-11-15 14:16 425

I-Mab Biopharma Receives IND Approval from NMPA to Initiate Clinical Trials for its Anti-GM-CSF Monoclonal Antibody TJM2 in China

SHANGHAI, Nov. 14, 2019 /PRNewswire/ -- I-Mab Biopharma ("I-Mab"), a China and U.S.-based clinical-stage biopharmaceutical company exclusively focused on the discovery and development of novel or highly differentiated biologics in immuno-oncology and autoimmune diseases today announced that Natio...

2019-11-14 23:45 391

China Jo-Jo Drugstores Reports Second Quarter 2020 Financial Results

HANGZHOU, China, Nov. 14, 2019 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a provider of healthcare services inChina, today a...

2019-11-14 22:00 5351

DOF ranks 1st in Korea Brand Preference Award for three consecutive years

SEOUL, South Korea, Nov. 14, 2019 /PRNewswire/ -- The global dental medical device brand DOF took the first place in the Korea Brand Preference Award (in the dental medical device section) for three consecutive years, at the ceremony held in the Riverside Hotel in Gangnam,Seoul, on the 22nd. Sp...

2019-11-14 21:00 232

Samsung Biologics Enhances Its Trusted Service as the First and Only ISO27001 Certified CDMO

INCHEON, South Korea, Nov. 14, 2019 /PRNewswire/ -- Samsung Biologics announced that it has obtained ISO 27001 certification, the most prestigious international standard on information security management. Samsung Biologics is the first CDMO company to be ISO 27001 certified globally. A ceremony...

2019-11-14 20:00 215

111, Inc. Announces Third Quarter 2019 Unaudited Financial Results

SHANGHAI, Nov. 14, 2019 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading integrated online and offline healthcare platform in China, today announced its unaudited financial results for the third quarter endedSeptember 30, 2019.  Third Quarter 2019 Highlights * Net rev...

2019-11-14 17:56 5384
12345 ... 531